Pharmacologic management of cardiovascular concerns is an intricate, evolving science that can stump even the most experienced NPs. The first of our two-part Comprehensive Cardiovascular Pharmacology series breaks down this complex field with a detailed review of the characteristics and pharmacologic treatment of hyperlipidemia and manifestations of coronary heart disease. Pharmacologic therapy for venous thromboembolism is also discussed in depth.
Specific drugs within commonly prescribed drug classes, including antiplatelet and antiarrhythmic agents, are also discussed. This session includes the latest guidelines from the American College of Cardiology, the American Heart Association, and the National Lipid Association, ensuring that you can provide efficient, high-quality pharmacologic therapy to your patients with cardiovascular disorders.